I
n clinical practice, there is an outstanding variability in the use of resources and results that are obtained. This variability is largely attributed to the differences in the availability of patient care services. To solve this problem, during the last years, clinical pathways (CPs) have been used as guidelines for decision making in terms of clinical evidence. 1 Nevertheless, the use of CP does not replace the clinical judgment of the professional.
CPs, initially developed for the nursing staff, 1,2 are plans designed to assist patients according to the available clinical evidence. 3 To achieve a steady improvement in the patient care, evaluations are regularly performed to assess the preestablished standards and the impact of clinical results on the patients. The development of CP in the Department of Urology has proved to be effective in the improvement of patient care, reducing the length of hospital stay, optimizing the use of available resources, and reducing the rate of surgery-related complications. Thus, a better quality of health care can be achieved. 4 In this context, the Department of Urology at the University Hospital La Paz in Madrid has attained a vast experience in the use of CP, implementing 13 of them since they were used for the first time in the beginning of 1999.
Laparoscopic radical prostatectomy (LRP) is a surgical technique that, despite the fact that it was
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developed 20 years ago, has not been fully developed until recently. 5 Since 1998, its use was extended as an alternative to other techniques, such as retropubic radical prostatectomy, which was widely used at that time, for patients with localized prostate cancer with no evidence of dissemination outside the prostate's limits or of extensive metastasis. The LRP has proved to be a safe and effective technique. However, there is no evidence for any significant clinical advantages for this technique in comparison with the retropubic radical prostatectomy. 6, 7 The LRP's main advantages are a decrease in blood loss, a faster recovery time, fewer complications in the abdominal wall, and better esthetic results. The main inconveniences are caused by its demand for longer operative time and the use of more technical resources. Besides, there are different technical variants of LRP (with transperitoneal or extraperitoneal approach or robot-assisted prostatectomies), with no evidence of different clinical results. 8 Moreover, there is a strong correlation between the surgeon's experience in the laparoscopic technique and clinical results. 9, 10 Despite this, the approximate number of surgical interventions that are required by an experienced surgeon using this technique is still unknown. 9, 11 Thus, several studies have proved the beneficial effects of experience on different clinical outcomes, such as operative time, patient blood loss, complications after surgery, or conversion to an open procedure. 9, [11] [12] [13] [14] [15] [16] [17] [18] [19] Nevertheless, the implementation of plans assisting the organization of patient care is essential in the improvement of key variables, such as hospital stay or the duration of bladder catheterization (common risk factors in nosocomial infections). 9 The LRP was performed through transperitoneal approach for the first time at the University Hospital La Paz in Madrid in 2002. Until this time, the radical prostatectomy was exclusively performed through retropubic approach using a CP in its application. In 
PURPOSE
The aim of this study was to evaluate and measure the impact that the CP implementation in LRP has had on postsurgery patient care (length of hospital stay and quality of care) and patient's clinical evolution after discharge.
MATERIALS AND METHODS
The CP in the LRP was implemented in the Urology Service at the University Hospital La Paz in Madrid for the first time in the year 2003, being revised and updated in December 2004. The strategy for bibliographical research was set up by using the following key words: laparoscopy, prostatectomy, prostatic neoplasms, and critical pathways. The search engines used were SUMSearch, TripDatabase, and Google in advanced search. This study included data about 86 prostate cancer patients who underwent LRP, distributed in 2 categories according to the date when the CP was implemented. The first group consisted of 26 patients operated in 2002 before CP implementation. The second group, with the other 60 patients, followed the CP during 2004 and 2005. Thus, for every patient who was operated before CP implementation, 2 other patients who were operated after the CP was implemented were chosen. In terms of the selection of patients, the group that did not follow the CP consisted of the total number of patients operated for prostate cancer by a laparoscopic approach since this new technique was first used until the CP was implemented, whereas the other 60 patients in CP were randomly chosen. The patients who were operated after 2003 were excluded from the study because it was preferable to establish a period of adaptation to the new assistance plan to avoid possible bias in the results.
The completion of this study included the creation of a document that collected the patients' sociodemographic data, clinical history, the provided care, medical treatments, nursing care, and the patients' clinical evolution throughout the first year after the intervention. The collection of this information was done in accordance with the patients' clinical 236 QUALITY MANAGEMENT IN HEALTH CARE/VOLUME 17, ISSUE 3, JULY-SEPTEMBER 2008 histories. For the 60 patients who followed the CP, CP documents that showed medical treatments and nursing care were also evaluated. This information was completed using the clinical variables that were registered in a database compiled by the Urology Department in relation to the implementation of this new technique. Data analysis was performed using the statistical software SPSS, Version 11.0.
Two study groups have been compared. One group consisted of patients who were operated before the CP implementation and the other group had patients who followed the CP implementation. Chi-square and Student t tests were used to compare qualitative and quantitative variables, respectively.
RESULTS
The patients were between 48 and 76 years old, with an average age of 65.54 ± 5.74 years. No significant differences were detected between the groups. Afterward, following results were obtained on comparing patients included in the CP group and those who were operated on before the CP implementation:
• Medical history. There are no differences in relation to the presence on any comorbidity (cancer, cardiovascular disease, or chronic respiratory pathology), neither are there differences in the existence of diabetes mellitus, hypertension, dyslipidemia, and tobacco or alcohol consumption (Table 1 ).
• Prostate cancer characteristics. The prostate volume in the ultrasound was larger in the CP group. The results for the rest of the parameters are shown in Table 2 .
• Surgical procedure. The duration of the surgical procedure was reduced from 377.7 to 172.3 minutes after the CP implementation. Thirty-six percent of the patients in the pre-CP group were administered some transfusion, as opposed to 5.5% of the patients in the CP group (95% CI for the reduction, 7.9, 53.2%; P = .001). There were also fewer transfusions in patients who underwent LRP in 2004 and 2005 (Table 3 ). The incidence of conversion to an open procedure was 11.5% (3 patients) in the group operated before the CP implementation, whereas all patients in the CP group underwent prostatectomy by laparoscopic approach.
• Complications. The rate of complications in the early postsurgery stage (first month after surgery)-bleeding, rectovesical fistula, ileus, deep vein thrombosis, etc-decreases from 16% in patients operated on before the CP implementation to 10% in patients after the CP implementation. However, these differences are not significant (95% CI for the difference, 24.8, 13.8).
• Hospital stay. Average hospital length of stay was reduced from 4.81 to 3.92 days in the group of patients who underwent the CP (95% CI for the difference, 2.26, 0.48) ( Table 3 ). The length of stay is longer than estimated (4 days) in 25% of the patients included in the CP group, as opposed to 36% in the pre-CP group. However, these differences are not significant (95% CI for the difference, 33.7, 14.5).
• Medication and hospital care.
• Use of medication. The average number of days that patients receive enoxaparin for deep vein thrombosis prophylaxis is reduced from 6.44 to 3.38 days. Results showing the differences in using medication and hospital care before and after the CP implementation are shown in Table 3 .
• Patients' courses after discharge. There is no difference in the rate of occurrence of erectile dysfunction and urinary incontinence, nor is there any difference in the frequency of biochemical recurrence during the first year after surgery among patients before and after the CP implementation. All patients from both groups were alive 1 year after surgery. Results on the patients' courses during the first year after discharge are shown in Table 4 .
DISCUSSION
CPs are integral and systematized plans of assistance for certain processes that let us establish the time sequence and duration of the activities performed by the hospital staff for the patient care. 5 These plans, besides reducing the length of time in hospital stay and optimizing the use of resources, improve the quality of patient care. 6 Among the tumor characteristics at baseline, we observed through ultrasound a larger volume of glands that had been operated on in 2004 and 2005 than the volume of glands had been operated on in 2002. This occurrence could be due to the fact that, nowadays, the initial restrictions in the indications for prostatectomy have been decreased. However, as indicated by Singh et al, 20 the size of the prostate is not significantly related to clinical results, such as the length of time in surgery, loss of blood during surgery, or hospital stay. According to this study's objective, the duration of surgery was significantly reduced after the CP implementation, being close and even shorter than the results obtained by other researchers (Table 5) . Likewise, the requests for postsurgery transfusions are fewer in the CP group. These improvements in patient care can be due to the greater experience acquired by the staff throughout time. 9, [12] [13] [14] [15] [16] [17] [18] [19] [20] The results that were obtained for postsurgery complications differ greatly from study to study (Table 5 ). This variability of results could be explained by the different assessment standards used by these authors. As for other results regarding medical care, the average length of stay was not significantly reduced. This could be due to the fact that new results have been compared with lengths of stay that were already quite short (4.81 days) and, consequently, there was not much room for improvement. It is important to highlight the fact that although there were longer lengths of hospital stay in some of the published studies than before the CP implementation, the use of this medical care program has intensified the differences even further, reducing the length of stay to 1 day before the CP implementation in both groups (Table 5) the CP implementation was higher than what the results of other studies show (Table 5) . After the CP implementation in 60 patients, none of them required open surgery. One of the possible explanations for this outcome could be the greater experience acquired by the professionals throughout time. 9, [12] [13] [14] [15] [16] [17] [18] [19] As for the hospital care, the duration of bladder catheterization was reduced by almost 10 days after the CP implementation. Nevertheless, our results are still far from 7 days that other studies were able to produce, which are recommended in order to reduce the risk of complications to the minimum (Table 6) . 34, 35 There is a high risk of acute retention (10.4%) when the catheter is removed between second day and fourth day after surgery. 36 The risk of urinary tract infections (UTIs) is increased after 10th day, with a 26% rate of a Defined as the use of a protection system (pads) against urine leakage. b Defined as the inability to get an erection and drug therapy does no work (patients with erectile dysfunction at baseline are excluded from the analysis). c Defined as the measurable serum prostate-specific antigen levels after surgery. bacteriuria that increases by 5% for every extra day of catheterization. 37 For medication intake after the CP implementation, only the duration of thromboprophylaxis with low-molecular-weight heparin was significantly reduced.
Toward the end of the first year, no significant differences were found between patients operated on before and after the CP implementation in terms of incontinence, erectile dysfunction, biochemical recurrence, or survival rates. Recovery rates for continence and erectile functionality 3, 6, and 12 months after surgery, in comparison with other studies, are shown in Table 6 . We perceive differences in the results, which can be attributed to the use of different strategies to measure, interpret, and register these variables. 36 Some of these studies have also evaluated the patients' quality of life after surgery. 32, 33 
CONCLUSION
After the CP implementation in the LRP, there have been better results in patient care, such as reducing the duration of bladder catheterization (which reduces the risk of UTIs) and shortening the time of thromboprophylaxis with enoxaparin (which reduces the risk of bleeding). The improvement achieved in some of the variables, such as shortening the operative time, decreasing the loss of blood, and reducing the number of transfusions, could be attributed to the degree of experience of surgeons in this new technique. On comparing the findings of this study with those of other published studies, a clear reduction in length of stay and operative time was observed. However, there is still room for improvement in reducing the duration of bladder catheterization. Moreover, it is important that future studies should be conducted for a longer period of time and also to evaluate the clinical results in terms of quality of life.
